Sponsor: UCB Biopharma SRL
Sponsor Study ID: ONC001
Study Title: A Phase 1/2 Open Label, Multicenter Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of UCB6114 Administered Intravenously to Participants With Advanced Solid Tumors
CTO #: 103359
NCT Number: NCT04393298
Phase: I/II
Protocol Type: Treatment
Age Group: Adults
Disease Sites: Colon; Other Digestive Organ
Study Objectives: The purpose of the study is to characterize the safety and pharmacokinetic (PK) profile of UCB6114.